Kuo YH - Search Results

1

LAMC2 is a potential prognostic biomarker for cholangiocarcinoma.

Ong KH, Hsieh YY, Lai HY, Sun DP, Chen TJ, Huang SK, Tian YF, Chou CL, Shiue YL, Wu HC, Chan TC, Tsai HH, Li CF, Kuo YH. Ong KH, et al. Among authors: kuo yh. Oncol Lett. 2023 Oct 30;26(6):533. doi: 10.3892/ol.2023.14120. eCollection 2023 Dec. Oncol Lett. 2023. PMID: 38020294 Free PMC article.

2

Inferior survival of advanced pancreatic cancer patients who received gemcitabine-based chemotherapy but did not participate in clinical trials.

Yang SH, Kuo YH, Tien YW, Hsu C, Hsu CH, Kuo SH, Cheng AL. Yang SH, et al. Among authors: kuo yh, kuo sh. Oncology. 2011;81(3-4):143-50. doi: 10.1159/000330817. Epub 2011 Oct 19. Oncology. 2011. PMID: 22024966

3

Elovl6 is a poor prognostic predictor in breast cancer.

Feng YH, Chen WY, Kuo YH, Tung CL, Tsao CJ, Shiau AL, Wu CL. Feng YH, et al. Among authors: kuo yh. Oncol Lett. 2016 Jul;12(1):207-212. doi: 10.3892/ol.2016.4587. Epub 2016 May 16. Oncol Lett. 2016. PMID: 27347126 Free PMC article.

4

Expression of prothymosin α in lung cancer is associated with squamous cell carcinoma and smoking.

Kuo YH, Shiau AL, Tung CL, Su YC, Li CF, Su BH, Tsao CJ, Wu CL, Feng YH, Wu P. Kuo YH, et al. Oncol Lett. 2019 Jun;17(6):5740-5746. doi: 10.3892/ol.2019.10248. Epub 2019 Apr 12. Oncol Lett. 2019. PMID: 31105795 Free PMC article.

5

Effect of radiotherapy on survival in advanced hepatocellular carcinoma patients treated with sorafenib: a nationwide cancer-registry-based study.

Chu SS, Kuo YH, Liu WS, Wang SC, Ho CH, Chen YC, Yang CC, Wu HC. Chu SS, et al. Among authors: kuo yh. Sci Rep. 2021 Jan 15;11(1):1614. doi: 10.1038/s41598-021-81176-w. Sci Rep. 2021. PMID: 33452421 Free PMC article.

6

Adjuvant Radiotherapy Significantly Increases Neck Control and Survival in Early Oral Cancer Patients with Solitary Nodal Involvement: A National Cancer Registry Database Analysis.

Tsai CJ, Kuo YH, Wu HC, Ho CH, Chen YC, Yang CC. Tsai CJ, et al. Among authors: kuo yh. Cancers (Basel). 2021 Jul 26;13(15):3742. doi: 10.3390/cancers13153742. Cancers (Basel). 2021. PMID: 34359643 Free PMC article.

7

Overexpression of Pyruvate Dehydrogenase Kinase-3 Predicts Poor Prognosis in Urothelial Carcinoma.

Kuo YH, Chan TC, Lai HY, Chen TJ, Wu LC, Hsing CH, Li CF. Kuo YH, et al. Front Oncol. 2021 Sep 13;11:749142. doi: 10.3389/fonc.2021.749142. eCollection 2021. Front Oncol. 2021. PMID: 34589439 Free PMC article.

8

Optimal Lymph Node Yield for Survival Prediction in Rectal Cancer Patients After Neoadjuvant Therapy.

Lin YM, Chou CL, Kuo YH, Wu HC, Tsai CJ, Ho CH, Chen YC, Yang CC, Lin CW. Lin YM, et al. Among authors: kuo yh. Cancer Manag Res. 2021 Oct 24;13:8037-8047. doi: 10.2147/CMAR.S328666. eCollection 2021. Cancer Manag Res. 2021. PMID: 34729022 Free PMC article.

9

Complete and Durable Response to Nivolumab in Recurrent Poorly Differentiated Pancreatic Neuroendocrine Carcinoma with High Tumor Mutational Burden.

Kang NW, Tan KT, Li CF, Kuo YH. Kang NW, et al. Among authors: kuo yh. Curr Oncol. 2021 Nov 10;28(6):4587-4596. doi: 10.3390/curroncol28060388. Curr Oncol. 2021. PMID: 34898561 Free PMC article.

10

Angiogenesis Driven by the CEBPD-hsa-miR-429-VEGFA Signaling Axis Promotes Urothelial Carcinoma Progression.

Chan TC, Hsing CH, Shiue YL, Huang SK, Hsieh KL, Kuo YH, Li CF. Chan TC, et al. Among authors: kuo yh. Cells. 2022 Feb 11;11(4):638. doi: 10.3390/cells11040638. Cells. 2022. PMID: 35203290 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,222 results

Search Page

Filters